Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis C

  Free Subscription

Articles published in
Ann Intern Med
    October 2020
  1. ABRAHAM GM, Obley AJ, Humphrey LL, Qaseem A, et al
    World Health Organization Guidelines on Treatment of Hepatitis C Virus Infection: Best Practice Advice From the American College of Physicians.
    Ann Intern Med. 2020 Oct 6. doi: 10.7326/M19-3860.
    >> Share

    September 2020
  2. DURAND CM, Barnaba B, Yu S, Brown DM, et al
    Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study.
    Ann Intern Med. 2020 Sep 8. doi: 10.7326/M20-1468.
    >> Share

  3. KAPLAN DE
    Hepatitis C Virus.
    Ann Intern Med. 2020;173:ITC33-ITC48.
    >> Share

    July 2020
  4. KORETZ RL
    USPSTF recommends screening adults 18 to 79 years for hepatitis C virus infection (moderate certainty).
    Ann Intern Med. 2020;173:JC1.
    >> Share

    December 2019
  5. TURNER BJ, Rochat A, Lill S, Bobadilla R, et al
    Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
    Ann Intern Med. 2019 Dec 3. pii: 2756853. doi: 10.7326/M18-3573.
    >> Share

    November 2019

  6. Correction: Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus in Chronic Kidney Disease.
    Ann Intern Med. 2019;171:684.
    >> Share

    September 2019
  7. GORDON CE, Berenguer MC, Doss W, Fabrizi F, et al
    Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
    Ann Intern Med. 2019 Sep 24. pii: 2751913. doi: 10.7326/M19-1539.
    >> Share

    August 2019
  8. SIMON TG, Duberg AS, Aleman S, Hagstrom H, et al
    Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Ann Intern Med. 2019 Aug 20. pii: 2748619. doi: 10.7326/M18-2753.
    >> Share

    April 2019
  9. AKIYAMA MJ, Norton BL, Arnsten JH, Agyemang L, et al
    Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.
    Ann Intern Med. 2019 Apr 9. pii: 2730524. doi: 10.7326/M18-1715.
    >> Share

    December 2018
  10. ECKMAN MH, Woodle ES, Thakar CV, Paterno F, et al
    Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.
    Ann Intern Med. 2018;169:898-899.
    >> Share

  11. KIBERD B, Doucette K, Vinson A, Tennankore K, et al
    Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.
    Ann Intern Med. 2018;169:897-898.
    >> Share

    September 2018
  12. FEKETE T
    The Xpert HCV Viral Load Finger-Stick point-of-care test was accurate for detecting HCV RNA.
    Ann Intern Med. 2018;169:JC35.
    >> Share

    August 2018
  13. SHARIF A
    Transplanting Kidneys From Hepatitis C-Infected Donors Into Uninfected Recipients: Ready for the Mainstream.
    Ann Intern Med. 2018 Aug 7. pii: 2696496. doi: 10.7326/M18-1781.
    >> Share

  14. REESE PP, Abt PL, Blumberg EA, Van Deerlin VM, et al
    Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.
    Ann Intern Med. 2018 Aug 7. pii: 2696495. doi: 10.7326/M18-0749.
    >> Share

    July 2018
  15. ECKMAN MH, Woodle ES, Thakar CV, Paterno F, et al
    Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis.
    Ann Intern Med. 2018 Jul 10. pii: 2687656. doi: 10.7326/M17-3088.
    >> Share


  16. Kidney Transplants for Patients With Hepatitis C Virus Infection.
    Ann Intern Med. 2018 Jul 10. pii: 2687655. doi: 10.7326/P18-0010.
    >> Share

  17. GOLDBERG DS, Reese PP
    New Insights Into Optimal Timing of Hepatitis C Virus Treatment for Dialysis Patients Waitlisted for Kidney Transplant.
    Ann Intern Med. 2018 Jul 10. pii: 2687654. doi: 10.7326/M18-1718.
    >> Share

    May 2018
  18. SOOD N, Ung D, Shankar A, Strom BL, et al
    A Novel Strategy for Increasing Access to Treatment for Hepatitis C Virus Infection for Medicaid Beneficiaries.
    Ann Intern Med. 2018 May 15. pii: 2681481. doi: 10.7326/M18-0186.
    >> Share

  19. NAKAMURA H, Fujieda Y, Yasuda S, Nakai M, et al
    Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus.
    Ann Intern Med. 2018 May 1. pii: 2680058. doi: 10.7326/L17-0759.
    >> Share

  20. BELPERIO PS, Chartier M, Ross DB
    After Curing Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:682-683.
    >> Share

  21. DEBES JD
    After Curing Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:682.
    >> Share

    April 2018
  22. DURAND CM, Bowring MG, Thomas AG, Kucirka LM, et al
    The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study.
    Ann Intern Med. 2018 Apr 17. pii: 2678899. doi: 10.7326/M17-2451.
    >> Share

    March 2018
  23. EMMANUEL B, Masur H, Kottilil S, Kattakuzhy S, et al
    Expansion of Treatment for Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:457-459.
    >> Share

  24. ROMANO MJ
    Expansion of Treatment for Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:456-457.
    >> Share

  25. KATAREY D
    Expansion of Treatment for Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:457.
    >> Share

  26. DURAND CM, Bowring MG, Brown DM, Chattergoon MA, et al
    Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.
    Ann Intern Med. 2018 Mar 6. pii: 2674335. doi: 10.7326/M17-2871.
    >> Share

    January 2018
  27. ENOMOTO M, Tateishi C, Tsuruta D, Tamori A, et al
    Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
    Ann Intern Med. 2018 Jan 16. pii: 2669850. doi: 10.7326/L17-0613.
    >> Share

    November 2017
  28. BERSOFF-MATCHA SJ, Cao K, Jason M, Jones SC, et al
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus.
    Ann Intern Med. 2017;167:760.
    >> Share

  29. MAHALE P, Glenn JS, O'Brien TR
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus.
    Ann Intern Med. 2017;167:759-760.
    >> Share

    October 2017
  30. LOK AS, Chung RT, Vargas HE, Kim AY, et al
    Benefits of Direct-Acting Antivirals for Hepatitis C.
    Ann Intern Med. 2017 Oct 17. doi: 10.7326/M17-1876.
    >> Share

  31. BELPERIO PS, Chartier M, Ross DB, Alaigh P, et al
    Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.
    Ann Intern Med. 2017;167:499-504.
    >> Share

    August 2017
  32. KATTAKUZHY S, Gross C, Emmanuel B, Teferi G, et al
    Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
    Ann Intern Med. 2017 Aug 8. doi: 10.7326/M17-0118.
    >> Share

  33. SCHVARTSMAN G, Perez K, Sood G, Katkhuda R, et al
    Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma.
    Ann Intern Med. 2017 Aug 1. doi: 10.7326/L17-0187.
    >> Share

    July 2017
  34. SACKS HS
    Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response.
    Ann Intern Med. 2017;167:JC3.
    >> Share

    June 2017
  35. KANDATHIL AJ, Breitwieser FP, Sachithanandham J, Robinson M, et al
    Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs.
    Ann Intern Med. 2017 Jun 6. doi: 10.7326/M17-0085.
    >> Share

  36. GRAHAM CS
    Making Do With What We Have.
    Ann Intern Med. 2017;166:850-851.
    >> Share

    May 2017
  37. LY KN, Jiles RB, Teshale EH, Foster MA, et al
    Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014.
    Ann Intern Med. 2017 May 9. doi: 10.7326/M16-2350.
    >> Share

  38. JR AD
    Hearing From the Silent Epidemic.
    Ann Intern Med. 2017 May 9. doi: 10.7326/M17-0927.
    >> Share

    April 2017
  39. TALAL AH, Thomas DL, Reynolds JL, Khalsa JH, et al
    Toward Optimal Control of Hepatitis C Virus Infection in Persons With Substance Use Disorders.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M16-2887.
    >> Share

  40. BERSOFF-MATCHA SJ, Cao K, Jason M, Ajao A, et al
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M17-0377.
    >> Share

  41. BUCKLEY GJ, Strom BL
    A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.
    Ann Intern Med. 2017 Apr 4. doi: 10.7326/M17-0766.
    >> Share

    March 2017
  42. HOOFNAGLE JH, Sherker AH
    Hepatitis C: Down but Not Out.
    Ann Intern Med. 2017 Mar 21. doi: 10.7326/M17-0567.
    >> Share

  43. FALADE-NWULIA O, Suarez-Cuervo C, Nelson DR, Fried MW, et al
    Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.
    Ann Intern Med. 2017 Mar 21. doi: 10.7326/M16-2575.
    >> Share

  44. DI BIASE L, Picillo M, Freitas ME, Bui E, et al
    Hepatitis C Virus-Related Hepatic Myelopathy After Treatment With Sofosbuvir and Ribavirin: A Case Report.
    Ann Intern Med. 2017;166:379-380.
    >> Share

    November 2016
  45. COLOMBO M, Aghemo A, Liu H, Zhang J, et al
    Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial.
    Ann Intern Med. 2016 Nov 15. doi: 10.7326/M16-1205.
    >> Share

    October 2016
  46. WANG Q, De Luca A, Smith C, Zangerle R, et al
    Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
    Ann Intern Med. 2016 Oct 18. doi: 10.7326/M16-0240.
    >> Share

    April 2016
  47. BUCKLEY GJ, Strom BL
    What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?
    Ann Intern Med. 2016 Apr 12. doi: 10.7326/M16-0772.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016